期刊
KIDNEY INTERNATIONAL
卷 74, 期 6, 页码 791-798出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2008.295
关键词
anemia; chronic kidney disease; epoetin-alpha; dose; epidemiology and outcomes
资金
- NCRR NIH HHS [KL2 RR024127, 1KL2 RR024127] Funding Source: Medline
- NIDDK NIH HHS [K23DK075929, K23 DK075929, R01 DK080094-02, K23 DK075929-03, R01 DK080094] Funding Source: Medline
- NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024127] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080094, K23DK075929] Funding Source: NIH RePORTER
Trials of anemia correction in chronic kidney disease have found either no benefit or detrimental outcomes of higher targets. We did a secondary analysis of patients with chronic kidney disease enrolled in the Correction of Hemoglobin in the Outcomes in Renal Insufficiency trial to measure the potential for competing benefit and harm from achieved hemoglobin and epoetin dose trials. In the 4 month analysis, significantly more patients in the high-hemoglobin compared to the low-hemoglobin arm were unable to achieve target hemoglobin and required high-dose epoetin-alpha. In unadjusted analyses, the inability to achieve a target hemoglobin and high-dose epoetin-alpha were each significantly associated with increased risk of a primary endpoint (death, myocardial infarction, congestive heart failure or stroke). In adjusted models, high-dose epoetin-alpha was associated with a significant increased hazard of a primary endpoint but the risk associated with randomization to the high hemoglobin arm did not suggest a possible mediating effect of higher target via dose. Similar results were seen in the 9 month analysis. Our study demonstrates that patients achieving their target had better outcomes than those who did not; and among subjects who achieved their randomized target, no increased risk associated with the higher hemoglobin goal was detected. Prospective studies are needed to confirm this relationship and determine safe dosing algorithms for patients unable to achieve target hemoglobin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据